MYC overexpression or dysregulation has been implicated in a broad spectrum of malignancies, including breast, and ovarian cancers, among others (Zacarأas-Fluck et al., 2024; Bi et al., 2024). The gene discussed is MYC; the disease is ovarian cancer.